Asia Pacific Radiopharmaceutical Theranostics Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Radiopharmaceutical Theranostics Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Radiopharmaceutical Theranostics Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Radiopharmaceutical Theranostics Market Regional Analysis

6.2 Asia Pacific Radiopharmaceutical Theranostics Market Revenue 2020-2028 (US$ Million)

6.3 Asia Pacific Radiopharmaceutical Theranostics Market Forecast Analysis

7. Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Product Type

7.1 Alpha Emitters

7.1.1 Overview
7.1.2 Alpha Emitters: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Beta Emitters

7.2.1 Overview
7.2.2 Beta Emitters: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Positron Emission Tomography Tracers

7.3.1 Overview
7.3.2 Positron Emission Tomography Tracers: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Radioisotope

8.1 Technetium-99

8.1.1 Overview
8.1.2 Technetium-99: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.2 Gallium-68

8.2.1 Overview
8.2.2 Gallium-68: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.3 Iodine-131

8.3.1 Overview
8.3.2 Iodine-131: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.4 Iodine-123

8.4.1 Overview
8.4.2 Iodine-123: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.5 Fluorine-18

8.5.1 Overview
8.5.2 Fluorine-18: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.6 Yttrium 90

8.6.1 Overview
8.6.2 Yttrium 90: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.7 Lutetium 177

8.7.1 Overview
8.7.2 Lutetium 177: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.8 Copper 67

8.8.1 Overview
8.8.2 Copper 67: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

8.9 Copper 64

8.9.1 Overview
8.9.2 Copper 64: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Source

9.1 Nuclear Reactors and Cyclotrons

9.1.1 Overview
9.1.2 Nuclear Reactors and Cyclotrons: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Asia Pacific Radiopharmaceutical Theranostics Market Analysis – by Application

10.1 Targeted Therapeutic

10.1.1 Overview
10.1.2 Targeted Therapeutic: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Companion Diagnostic

10.2.1 Overview
10.2.2 Companion Diagnostic: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Asia Pacific Radiopharmaceutical Theranostics Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific

11.2.1 Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast Analysis – by Country
11.2.1.1 China: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 China: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.1.2 China: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.1.3 China: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.1.4 China: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Application

11.2.1.2 India: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 India: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.2.2 India: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.2.3 India: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.2.4 India: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Application

11.2.1.3 Japan: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 Japan: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.3.2 Japan: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.3.3 Japan: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.3.4 Japan: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Application

11.2.1.4 Australia: Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Australia: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.4.2 Australia: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.4.3 Australia: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.4.4 Australia: Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Application

11.2.1.5 Rest of Asia-Pacific : Asia Pacific Radiopharmaceutical Theranostics Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Product Type
11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Radioisotope
11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Source
11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Radiopharmaceutical Theranostics Market Breakdown, by Application

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Bayer AG

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 GE Healthcare Technologies Inc.

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Curium

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Telix Pharmaceuticals Ltd.

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Cardinal Health Inc.

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Asia Pacific Radiopharmaceutical Theranostics Market